Skip to main content
SpringerLink
Log in

Complications of Kidney Transplantation

  • Chapter
  • First Online:
Clinical Decisions in Nephrology, Hypertension and Kidney Transplantation

Abstract

A 65-year-old recipient of a deceased donor kidney transplant presents for a routine evaluation. End-stage renal disease (ESRD) was due to adult autosomal dominant polycystic kidney disease. She received her transplant 4 months previously. Induction was accomplished by antithymocyte globulin and has been maintained on tacrolimus, mycophenolate mofetil, and prednisone. Her baseline creatinine had been between 1.1 and 1.4 mg/dL. She reports noticing some ankle swelling, weight gain, and increased home blood pressure readings. On exam she has 1+ pitting ankle edema; lungs are clear; heart regular with no murmur. Routine chemistry reveals a creatinine of 1.8 mg/dL.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 179.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 229.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Gottlieb RH, Voci SL, Cholewinski SP, et al. Sonography: a useful tool to detect the mechanical causes of renal transplant dysfunction. J Clin Ultrasound. 1999;27(6):325–33.

    Article  PubMed  CAS  Google Scholar 

  2. Englesbe MJ, Dubay DA, Gillespie BW, et al. Risk factors for urinary complications after renal transplantation. Am J Transplant. 2007;7(6):1536–41.

    Article  PubMed  CAS  Google Scholar 

  3. Kobayashi K, Censullo ML, Rossman LL, Kyriakides PN, Kahan BD, Cohen AM. Interventional radiologic management of renal transplant dysfunction: indications, limitations, and technical considerations. Radiographics. 2007;27(4):1109–30.

    Article  PubMed  Google Scholar 

  4. Rosenberg RJ, Schweizer RT, Spencer RP. Ureteral leak after renal transplantation. Clin Nucl Med. 1999;24(6):440–2.

    Article  PubMed  CAS  Google Scholar 

  5. Smith TP, Hunter DW, Letourneau JG, et al. Urine leaks after renal transplantation: value of percutaneous pyelography and drainage for diagnosis and treatment. AJR Am J Roentgenol. 1988;151(3):511–3.

    PubMed  CAS  Google Scholar 

  6. Matalon TA, Thompson MJ, Patel SK, Ramos MV, Jensik SC, Merkel FK. Percutaneous treatment of urine leaks in renal transplantation patients. Radiology. 1990;174(3 Pt 2):1049–51.

    PubMed  CAS  Google Scholar 

  7. Doehn C, Fornara P, Fricke L, Jocham D. Laparoscopic fenestration of posttransplant lymphoceles. Surg Endosc. 2002;16(4):690–5.

    Article  PubMed  CAS  Google Scholar 

  8. Bailey SH, Mone MC, Holman JM, Nelson EW. Laparoscopic treatment of post renal transplant lymphoceles. Surg Endosc. 2003;17(12):1896–9.

    Article  PubMed  CAS  Google Scholar 

  9. Zargar-Shoshtari MA, Soleimani M, Salimi H, Mehravaran K. Symptomatic lymphocele after kidney transplantation: a single-center experience. Urol J Winter. 2008;5(1):34–6.

    Google Scholar 

  10. Shaver TR, Swanson III SJ, Fernandez-Bueno C, Kocandrle V. The optimal treatment of lymphoceles following renal transplantation. Transpl Int. 1993;6(2):108–10.

    Article  PubMed  CAS  Google Scholar 

  11. Montalvo BM, Yrizarry JM, Casillas VJ, et al. Percutaneous sclerotherapy of lymphoceles related to renal transplantation. J Vasc Interv Radiol. 1996;7(1):117–23.

    Article  PubMed  CAS  Google Scholar 

  12. Tasar M, Gulec B, Saglam M, Yavuz I, Bozlar U, Ugurel S. Posttransplant symptomatic lymphocele treatment with percutaneous drainage and ethanol sclerosis: long-term follow-up. Clin Imaging. 2005;29(2):109–16.

    Article  PubMed  Google Scholar 

  13. Chin A, Ragavendra N, Hilborne L, Gritsch HA. Fibrin sealant sclerotherapy for treatment of lymphoceles following renal transplantation. J Urol. 2003;170(2 Pt 1):380–3.

    Article  PubMed  Google Scholar 

  14. Garay JM, Alberu J, Angulo-Suarez M, Bezauri-Rivas P, Herrera MF. Laparoscopic drainage of lymphocele after kidney transplant. J Laparoendosc Adv Surg Tech A. 2003;13(2):127–9.

    Article  PubMed  Google Scholar 

  15. Yannam GR, Gutti TL, High R, Stevens RB, Thompson JS, Morris MC. Experience of laparoscopic incisional hernia repair in kidney and/or pancreas transplant recipients. Am J Transplant. 2011;11(2):279–86.

    Article  PubMed  CAS  Google Scholar 

  16. Laschke MW, Haufel JM, Roller J, Schorr H, Menger MD. Rapamycin, but not cyclosporine A, inhibits vascularization and incorporation of implanted surgical meshes. Transpl Int. 2009;22(6):654–62.

    Article  PubMed  CAS  Google Scholar 

  17. Humar A, Ramcharan T, Denny R, Gillingham KJ, Payne WD, Matas AJ. Are wound complications after a kidney transplant more common with modern immunosuppression? Transplantation. 2001;72(12):1920–3.

    Article  PubMed  CAS  Google Scholar 

  18. Antonopoulos IM, Nahas WC, Mazzucchi E, Piovesan AC, Birolini C, Lucon AM. Is polypropylene mesh safe and effective for repairing infected incisional hernia in renal transplant recipients? Urology. 2005;66(4):874–7.

    Article  PubMed  Google Scholar 

  19. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant. 2008;8(4):753–60.

    Article  PubMed  CAS  Google Scholar 

  20. Sis B, Mengel M, Haas M, et al. Banff ‘09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant. 2010;10(3):464–71.

    Article  PubMed  CAS  Google Scholar 

  21. Rush D. Protocol biopsies for renal transplantation. Saudi J Kidney Dis Transpl. 2010;21(1):1–9.

    PubMed  Google Scholar 

  22. Meier-Kriesche HU, Ojo A, Magee JC, et al. African-American renal transplant recipients experience decreased risk of death due to infection: possible implications for immunosuppressive strategies. Trans­plantation. 2000;70(2):375–9.

    Article  PubMed  CAS  Google Scholar 

  23. Meier-Kriesche HU, Scornik JC, Susskind B, Rehman S, Schold JD. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients. Transplantation. 2009;88(1):23–9.

    Article  PubMed  Google Scholar 

  24. El-Zoghby ZM, Stegall MD, Lager DJ, et al. Identifying specific causes of kidney allograft loss. Am J Transplant. 2009;9(3):527–35.

    Article  PubMed  CAS  Google Scholar 

  25. Cosio FG, Gloor JM, Sethi S, Stegall MD. Transplant glomerulopathy. Am J Transplant. 2008;8(3):492–6.

    Article  PubMed  CAS  Google Scholar 

  26. Amer H, Fidler ME, Myslak M, et al. Proteinuria after kidney transplantation, relationship to allograft histology and survival. Am J Transplant. 2007;7(12):2748–56.

    Article  PubMed  CAS  Google Scholar 

  27. Amer H, Cosio FG. Significance and management of proteinuria in kidney transplant recipients. J Am Soc Nephrol. 2009;20(12):2490–2.

    Article  PubMed  Google Scholar 

  28. Halimi JM, Buchler M, Al-Najjar A, et al. Urinary albumin excretion and the risk of graft loss and death in proteinuric and non-proteinuric renal transplant recipients. Am J Transplant. 2007;7(3):618–25.

    Article  PubMed  CAS  Google Scholar 

  29. Letavernier E, Bruneval P, Mandet C, et al. High sirolimus levels may induce focal segmental glomerulosclerosis de novo. Clin J Am Soc Nephrol. 2007;2(2):326–33.

    Article  PubMed  CAS  Google Scholar 

  30. Bertoni E, Bruschi M, Candiano G, et al. Posttransplant proteinuria associated with everolimus. Transplant Proc. 2009;41(4):1216–7.

    Article  PubMed  CAS  Google Scholar 

  31. Knoll GA. Proteinuria in kidney transplant recipients: prevalence, prognosis, and evidence-based management. Am J Kidney Dis. 2009;54(6):1131–44.

    Article  PubMed  Google Scholar 

  32. Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet. 1971;1(7712):1253–7.

    Article  PubMed  CAS  Google Scholar 

  33. Gardner SD. Prevalence in England of antibody to human polyomavirus (B.k.). Br Med J. 1973;1(5845):77–8.

    Article  PubMed  CAS  Google Scholar 

  34. Funk GA, Hirsch HH. From plasma BK viral load to allograft damage: rule of thumb for estimating the intrarenal cytopathic wear. Clin Infect Dis. 2009;49(6):989–90.

    Article  PubMed  Google Scholar 

  35. Hirsch HH, Suthanthiran M. The natural history, risk factors and outcomes of polyomavirus BK-associated nephropathy after renal transplantation. Nat Clin Pract Nephrol. 2006;2(5):240–1.

    Article  PubMed  Google Scholar 

  36. Boothpur R, Brennan DC. Human polyoma viruses and disease with emphasis on clinical BK and JC. J Clin Virol. 2010;47(4):306–12.

    Article  PubMed  Google Scholar 

  37. Bernhoff E, Gutteberg TJ, Sandvik K, Hirsch HH, Rinaldo CH. Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression. Am J Transplant. 2008;8(7):1413–22.

    Article  PubMed  CAS  Google Scholar 

  38. Bernhoff E, Tylden GD, Kjerpeseth LJ, Gutteberg TJ, Hirsch HH, Rinaldo CH. Leflunomide inhibition of BK virus replication in renal tubular epithelial cells. J Virol. 2010;84(4):2150–6.

    Article  PubMed  CAS  Google Scholar 

  39. Gabardi S, Waikar SS, Martin S, et al. Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation. Clin J Am Soc Nephrol. 2010;5(7):1298–304.

    Article  PubMed  CAS  Google Scholar 

  40. Eid AJ, Razonable RR. New developments in the management of cytomegalovirus infection after solid organ transplantation. Drugs. 2010;70(8):965–81.

    Article  PubMed  CAS  Google Scholar 

  41. Carroll RP, Ramsay HM, Fryer AA, Hawley CM, Nicol DL, Harden PN. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia. Am J Kidney Dis. 2003;41(3):676–83.

    Article  PubMed  Google Scholar 

  42. Wimmer CD, Rentsch M, Crispin A, et al. The Janus face of immunosuppression – de novo malignancy after renal transplantation: the experience of the transplantation center Munich. Kidney Int. 2007;71(12):1271–8.

    Article  PubMed  CAS  Google Scholar 

  43. Campistol JM, Eris J, Oberbauer R, et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J Am Soc Nephrol. 2006;17(2):581–9.

    Article  PubMed  CAS  Google Scholar 

  44. Salgo R, Gossmann J, Schofer H, et al. Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial. Am J Transplant. 2010;10(6):1385–93.

    Article  PubMed  CAS  Google Scholar 

  45. Evens AM, Roy R, Sterrenberg D, Moll MZ, Chadburn A, Gordon LI. Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy. Curr Oncol Rep. 2010;12(6):383–94.

    Article  PubMed  Google Scholar 

  46. Alangaden GJ, Thyagarajan R, Gruber SA, et al. Infectious complications after kidney transplantation: current epidemiology and associated risk factors. Clin Transplant. 2006;20(4):401–9.

    Article  PubMed  Google Scholar 

  47. Dantas SR, Kuboyama RH, Mazzali M, Moretti ML. Nosocomial infections in renal transplant patients: risk factors and treatment implications associated with urinary tract and surgical site infections. J Hosp Infect. 2006;63(2):117–23.

    Article  PubMed  CAS  Google Scholar 

  48. Pellé G, Vimont S, Levy PP, et al. Acute pyelonephritis represents a risk factor impairing long-term kidney graft function. Am J Transplant. 2007;7(4):899–907.

    Article  PubMed  Google Scholar 

  49. Abbott KC, Swanson SJ, Richter ER, et al. Late urinary tract infection after renal transplantation in the United States. Am J Kidney Dis. 2004;44(2):353–62.

    Article  PubMed  Google Scholar 

  50. Chuang P, Parikh CR, Langone A. Urinary tract infections after renal transplantation: a retrospective review at two US transplant centers. Clin Transplant. 2005;19(2):230–5.

    Article  PubMed  Google Scholar 

  51. Maraha B, Bonten H, Van Hooff H, Fiolet H, Buiting AG, Stobberingh EE. Infectious complications and antibiotic use in renal transplant recipients during a 1-year follow-up. Clin Microbiol Infect. 2001;7(11):619–25.

    Article  PubMed  CAS  Google Scholar 

  52. Kamath NS, John GT, Neelakantan N, Kirubakaran MG, Jacob CK. Acute graft pyelonephritis following renal transplantation. Transpl Infect Dis. 2006;8(3):140–7.

    Article  PubMed  CAS  Google Scholar 

  53. de Souza RM, Olsburgh J. Urinary tract infection in the renal transplant patient. Nat Clin Pract Neph. 2008;4(5):252–64.

    Article  Google Scholar 

  54. Green H, Rahamimov R, Gafter U, Leibovitci L, Paul M. Antibiotic prophylaxis for urinary tract infections in renal transplant recipients: a systematic review and meta-analysis. Transpl Infect Dis. 2011;13(5):441–7.

    Article  PubMed  CAS  Google Scholar 

  55. Rafat C, Vimont S, Ancel PY, et al. Ofloxacin: new applications for the prevention of urinary tract infections in renal graft recipients. Transpl Infect Dis. 2011;13(4):344–52.

    Article  PubMed  CAS  Google Scholar 

  56. Khosroshahi HT, Mogaddam AN, Shoja MM. Efficacy of high-dose trimethoprim-sulfamethoxazol prophylaxis on early urinary tract infection after renal transplantation. Transplant Proc. 2006;38(7):2062–4.

    Article  PubMed  CAS  Google Scholar 

  57. Wilson CH, Bhatti AA, Rix DA, Manas DM. Routine intraoperative ureteric stenting for kidney transplant recipients. Cochrane Database Syst Rev. 2005;(4):CD004925.

    Google Scholar 

  58. Giral M, Pascuariello G, Karam G, et al. Acute graft pyelonephritis and long-term kidney allograft outcome. Kidney Int. 2002;61(5):1880–6.

    Article  PubMed  Google Scholar 

  59. Cohen DJ, St. Martin L, Christensen LL, Bloom RD, Sung RS. Kidney and pancreas transplantation in the United States, 1995–2004. Am J Transplant. 2006;6(5 Pt 2):1153–69.

    Article  PubMed  CAS  Google Scholar 

  60. Morzycka M, Croker Jr BP, Siegler HF, Tisher CC. Evaluation of recurrent glomerulonephritis in kidney allografts. Am J Med. 1982;72(4):588–98.

    Article  PubMed  CAS  Google Scholar 

  61. Kotanko P, Pusey CD, Levy JB. Recurrent glomerulonephritis following renal transplantation. Trans­plantation. 1997;63(8):1045–52.

    Article  PubMed  CAS  Google Scholar 

  62. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med. 2002;347(2):103–9.

    Article  PubMed  Google Scholar 

  63. Hariharan S, Adams MB, Brennan DC, et al. Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation. 1999;68(5):635–41.

    Article  PubMed  CAS  Google Scholar 

  64. Briggs JD, Jones E. Recurrence of glomerulonephritis following renal transplantation. Scientific Advisory Board of the ERA-EDTA Registry. European Renal Association-European Dialysis and Transplant Association. Nephrol Dial Transplant. 1999;14(3):564–5.

    Article  PubMed  CAS  Google Scholar 

  65. Ponticelli C, Traversi L, Feliciani A, Cesana BM, Banfi G, Tarantino A. Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int. 2001;60(5):1948–54.

    Article  PubMed  CAS  Google Scholar 

  66. Dall’Amico R, Ghiggeri G, Carraro M, et al. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis. 1999;34(6):1048–55.

    Article  PubMed  Google Scholar 

  67. Ingulli E, Tejani A. Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children–a single-center experience. Transplantation. 1991;51(2):401–5.

    Article  PubMed  CAS  Google Scholar 

  68. Ducloux D, Rebibou JM, Semhoun-Ducloux S, et al. Recurrence of hemolytic-uremic syndrome in renal transplant recipients: a meta-analysis. Transplantation. 1998;65(10):1405–7.

    Article  PubMed  CAS  Google Scholar 

  69. Mulay AV, van Walraven C, Knoll GA. Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis. Am J Transplant. 2009;9(4):804–11.

    Article  PubMed  CAS  Google Scholar 

  70. Ibrahim H, Rogers T, Casingal V, et al. Graft loss from recurrent glomerulonephritis is not increased with a rapid steroid discontinuation protocol. Transplantation. 2006;81(2):214–9.

    Article  PubMed  Google Scholar 

  71. El-Zoghby ZM, Grande JP, Fraile MG, Norby SM, Fervenza FC, Cosio FG. Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies. Am J Transplant. 2009;9(12):2800–7.

    Article  PubMed  CAS  Google Scholar 

  72. Gourishankar S, Leduc R, Connett J, et al. Pathological and clinical characterization of the ‘troubled transplant’: data from the DeKAF study. Am J Transplant. 2010;10(2):324–30.

    Article  PubMed  CAS  Google Scholar 

  73. Fervenza FC, Abraham RS, Erickson SB, et al. Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol. 2010;5(12):2188–98.

    Article  PubMed  CAS  Google Scholar 

  74. Hickson LJ, Gera M, Amer H, et al. Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence. Transplantation. 2009;87(8):1232–9.

    Article  PubMed  Google Scholar 

  75. Dello Strologo L, Guzzo I, Laurenzi C, et al. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation. Transplantation. 2009;88(3):417–20.

    Article  PubMed  Google Scholar 

  76. Fornoni A, Sageshima J, Wei C, et al. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med. 2011;3(85):85ra46.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology and Hypertension, Department of Medicine and the William J von Liebig Transplant Center, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA

    Hatem Amer M.D.

  2. Department of Transplantation, Mayo Clinic Florida, Jacksonville, FL, 32224, USA

    Lena Sibulesky M.D. & Hani M. Wadei M.D.

Authors
  1. Hatem Amer M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lena Sibulesky M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hani M. Wadei M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hatem Amer M.D. .

Editor information

Editors and Affiliations

  1. Chicago College of Medicine, Nephrology, University of Illinois, Wisconsin Avenue 3543, Berwyn, 60402, Illinois, USA

    Edgar V. Lerma

  2. , Division of Nephrology, University of Virginia Health System, Box 800133, Charlottesville, 22908, Virginia, USA

    Mitchell Rosner

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Amer, H., Sibulesky, L., Wadei, H.M. (2013). Complications of Kidney Transplantation. In: Lerma, E., Rosner, M. (eds) Clinical Decisions in Nephrology, Hypertension and Kidney Transplantation. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4454-1_36

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-4454-1_36

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-4453-4

  • Online ISBN: 978-1-4614-4454-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation